{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:41:54Z","timestamp":1783446114130,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.yebeh.2019.06.022","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T06:18:06Z","timestamp":1562653086000},"page":"6-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"PA","title":["Epilepsy in neurofibromatosis type 1: Diffuse cerebral dysfunction?"],"prefix":"10.1016","volume":"98","author":[{"given":"Esra","family":"Serdaroglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahadir","family":"Konuskan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kader","family":"Karli Oguz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokce","family":"Gurler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Yalnizoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Anlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2019.06.022_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.yebeh.2019.06.022_bb0010","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/epi.12348","article-title":"Epilepsy in individuals with neurofibromatosis type 1","volume":"54","author":"Ostendorf","year":"2013","journal-title":"Epilepsia"},{"issue":"41","key":"10.1016\/j.yebeh.2019.06.022_bb0015","article-title":"Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?","volume":"44","author":"Santoro","year":"2018","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.yebeh.2019.06.022_bb0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.yebeh.2019.06.022_bb0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"Suppl. 10","key":"10.1016\/j.yebeh.2019.06.022_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1528-1167.2005.00353.x","article-title":"Neurocutaneous syndromes and epilepsy-issues in diagnosis and management","volume":"46","author":"Cross","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.022_bb0035","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.seizure.2011.04.016","article-title":"Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects","volume":"20","author":"Hsieh","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.06.022_bb0040","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0887-8994(98)00075-7","article-title":"Seizures in neurofibromatosis 1","volume":"19","author":"Kulkantrakorn","year":"1998","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2019.06.022_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.yebeh.2017.05.011","article-title":"Epilepsy in neurofibromatosis type 1","volume":"73","author":"Pecoraro","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.06.022_bb0050","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/08830738030180050501","article-title":"Epilepsy in neurofibromatosis 1","volume":"18","author":"Vivarelli","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2019.06.022_bb0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/ped.13388","article-title":"Neurological comorbidity in children with neurofibromatosis type 1","volume":"60","author":"Hirabaru","year":"2018","journal-title":"Pediatr Int"},{"key":"10.1016\/j.yebeh.2019.06.022_bb0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/088307380401900406","article-title":"Prevalence of epilepsy in Turkish children between the ages of 0 and 16 years","volume":"19","author":"Serdaroglu","year":"2004","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2019.06.022_bb0065","article-title":"An update on the central nervous system manifestations of neurofibromatosis type 1","author":"Nix","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"87","key":"10.1016\/j.yebeh.2019.06.022_bb0070","article-title":"Epilepsy mechanisms in neurocutaneous disorders: tuberous sclerosis complex, neurofibromatosis type 1, and Sturge-Weber syndrome","volume":"8","author":"Stafstrom","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2019.06.022_bb0075","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1007\/s12035-016-9907-1","article-title":"Sensitization of ion channels contributes to central and peripheral dysfunction in neurofibromatosis type 1","volume":"54","author":"Moutal","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"3","key":"10.1016\/j.yebeh.2019.06.022_bb0080","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.ejhg.5201978","article-title":"NF1 microduplication first clinical report: association with mild mental retardation, early onset of baldness and dental enamel hypoplasia?","volume":"16","author":"Grisart","year":"2008","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"10.1016\/j.yebeh.2019.06.022_bb0085","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/gim.2011.46","article-title":"NF1 microduplications: identification of seven nonrelated individuals provides further characterization of the phenotype","volume":"14","author":"Moles","year":"2012","journal-title":"Genet Med"},{"issue":"15","key":"10.1016\/j.yebeh.2019.06.022_bb0090","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.18632\/oncotarget.2194","article-title":"The NF1 gene revisited \u2014 from bench to bedside","volume":"5","author":"Yap","year":"2014","journal-title":"Oncotarget."},{"key":"10.1016\/j.yebeh.2019.06.022_bb0095","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/j.1651-2227.2010.01923.x","article-title":"Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1","volume":"99","author":"Feldmann","year":"2010","journal-title":"Acta Paediatr"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019303130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019303130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:29:26Z","timestamp":1761503366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019303130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":19,"alternative-id":["S1525505019303130"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.06.022","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epilepsy in neurofibromatosis type 1: Diffuse cerebral dysfunction?","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}